KLRK1 and glioma: Besides, the NKG2D-BBz CAR-T cells efficiently kill glioblastoma cells and glioma stem cells in vitro and produce high levels of TNF-α, perforin, and granzyme B. The CAR-T cells greatly reduce xenograft tumor burden in vivo and do not show significant treatment-related toxicity in the treated mice.